Filter
52
Filtered Results: 52
Text search:
United
States
Pharmacopeial
Convention
Featured
Recommendations
5
New Publications
13
Language
Document type
No document type
19
Guidelines
13
Studies & Reports
10
Manuals
5
Training Material
3
Strategic & Response Plan
2
Countries / Regions
Rwanda
2
Uganda
2
India
2
Kenya
1
Nigeria
1
Malawi
1
Global
1
Tanzania
1
Botswana
1
Liberia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
11
Guidelines
7
Laboratory Quality Assurance
4
Paediatrics
2
Bacteriology
2
Snakebites
2
Pharmaceutical Assessments
2
Policies
2
Maternal Health
2
Pharmacy & Technologies
2
Clinical Training
1
Emergency Health Kits
1
Pharmacy & Technology
1
Infection Control & Prevention (IPC)
1
Pediatrics
1
Vaccine-preventable Diseases
1
Studies & Reports
1
Statistics
1
Gynaecology & Obstetrics
1
Health Systems
1
NTDs & Others
1
TB
1
Toolboxes
Traditional & Herbal Medicines
7
Quality Assurance
6
Pharmacy Practice
5
Falsified & Substandard
4
Pharmaceutical Assessments
3
Rational use of Medicine
3
Biodiversity shift
2
Supply Chain & Store Management
2
Prevention & Control
1
SOPs
1
Diagnostics & Laboratory Guidance
1
Essential Medicines & Medical Devices
1
Reports
1
Essential Medicines
1
Model Formulary
1
Strategies
1
General Guidelines for Rational Use
1
Pharmaceutical Dosage Forms
1
Pharmacovigilance
1
General
1
Health Care In Conflict Settings
1
Clinical Aspects & Diagnostics
1
Snakebite envenoming
1
Education of students & professionals
1
Research & Access
1
Clinical Guidelines
1
Assessment
1
Western & Central Europe
1
Eastern Europe & Central Asia
1
chipsy-bekonowe
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Kit sanitaire d’urgence interinstitutions
recommended
Médicaments et dispositifs médicaux pour une population de
10 000 personnes pendant environ 3 mois
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch...
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
Handbook of HUMANITARIAN HEALTH CARE LOGISTICS Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies
A comprehensive compilation is provided of the medicinal plants of the Southeast Asian country of Myanmar (formerly Burma). This contribution, containing 123 families, 367 genera, and 472 species, was compiled from earlier treatments, monographs, books, and pamphlets, with some medicinal uses and pr...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
An Act to provide for the efficient and comprehensive regulation and control of food, drugs, medical devices, cosmetics, herbal drugs and poisons and to repeal the Food
(Control of Quality) Act, 1978, the Pharmaceuticals and Poisons Act, 1978 and to provide for related matters.
Drug Distribution and Control: Preparation and Handling–Guidelines
Review 2008
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
